These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 13891254)

  • 1. [General review of the toxic side-effects caused by hydantoin derivatives used in epilepsy].
    FACCHETTI G
    Cervello G Nevrol; 1962 Mar; 38():147-60. PubMed ID: 13891254
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemopoietic complications of hydantoin therapy of epilepsy].
    MANNHEIMER E; PAKESCH F; REIMER EE; VETTER H
    Med Klin; 1952 Oct; 47(42):1397-1401. PubMed ID: 13001915
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of 3-methyl-5, 5-phenyl-ethyl-hydantoin in therapy of epilepsy].
    HOLTZER PA
    Belg Tijdschr Geneesk; 1952 Sep; 8(18):817-31. PubMed ID: 13008950
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperplastic gingival changes as a side-effect of hydantoin treatment of epilepsy].
    PORT T
    Zahnarztl Welt; 1954 Jul; 9(14):382-3. PubMed ID: 13206054
    [No Abstract]   [Full Text] [Related]  

  • 5. N-methylated derivatives of barbituric acid, hydantoin and oxazolidinedione used in the treatment of epilepsy.
    BUTLER TC; WADDELL WJ
    Neurology; 1958 Apr; 8(Suppl 1):106-12. PubMed ID: 13541627
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hyperplastic gingival changes as a side-effect of hydantoin treatment of epilepsy; remarks on Dr. Port's paper].
    TRACKSDORF H
    Zahnarztl Welt; 1954 Nov; 9(22):641-3. PubMed ID: 14360136
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hydantoin therapy in epilepsy].
    STRAUCH W
    Dtsch Gesundheitsw; 1953 May; 8(20):591-601. PubMed ID: 13067813
    [No Abstract]   [Full Text] [Related]  

  • 8. [For hydantoin treatment of epilepsy].
    FRANKL VE
    Wien Z Nervenheilkd Grenzgeb; 1948; 1(2-3):284. PubMed ID: 18933032
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of 1-methyl-5,5-phenyl-ethyl-hydantoin in the treatment of epilepsy.
    LIVINGSTON S; PAULI LL; KRAMER I; NAJMABADI A
    N Engl J Med; 1961 Aug; 265():418-21. PubMed ID: 13762831
    [No Abstract]   [Full Text] [Related]  

  • 10. [Our experiences in the treatment of epilepsy with methyl-phenyl-ethyl-hydantoin].
    ROGER J; ROGER A
    Prog Med (Paris); 1958 Feb; 86(4):67. PubMed ID: 13527523
    [No Abstract]   [Full Text] [Related]  

  • 11. Epilepsy; treatment with new drug; 3-methyl 5,5-phenyl-ethyl-hydantoin (phenantoin).
    KOZOL HL
    Am J Psychiatry; 1946 Sep; 103(2):154-8. PubMed ID: 21001983
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lymph node manifestations during methyl-phenyl-ethyl-hydantoin therapy].
    OLMER J; PAILLAS J; ROGER J; MURATORE R; BADIER M
    Presse Med (1893); 1952 Dec; 60(82):1748-50. PubMed ID: 13027182
    [No Abstract]   [Full Text] [Related]  

  • 13. [Apropos of neurological complications of the treatment of epilepsy by hydantoins].
    ROGER J; SOULAYROL R
    Rev Neurol (Paris); 1959 Jun; 100():783-5. PubMed ID: 14438340
    [No Abstract]   [Full Text] [Related]  

  • 14. THE TREATMENT OF EPILEPSY WITH METHYLPHENYLETHYL HYDANTOIN (MESANTOIN).
    Aird RB
    Calif Med; 1948 Mar; 68(3):141-6. PubMed ID: 18731395
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in the electroencephalogram following administration o mesantoin (methyl-phenyl-ethyl hydantoin).
    LITTLE SC; McAVOY M
    Electroencephalogr Clin Neurophysiol; 1949 Aug; 1(3):325-32. PubMed ID: 18135424
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary changes in hydantoin therapy.
    MOORE MT
    J Am Med Assoc; 1959 Nov; 171():1328-33. PubMed ID: 14423879
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experiences with a new anti-epileptic drug: hydotin (3-methyl-5,5-diphenyl-hydantoin)].
    CASTELLUCCIO R
    Sem Med; 1952 Apr; 100(14):405-8. PubMed ID: 14942571
    [No Abstract]   [Full Text] [Related]  

  • 18. Spirodon (tetrantoin): a new anticonvulsant of the hydantoin group.
    PUTNAM TJ; JACOBS J
    Neurology; 1957 Nov; 7(11):784-8. PubMed ID: 13483836
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of adults for epilepsy; toxic effect of 3-methyl 5-5-phenylethylhydantoin.
    BAILEY AA; WORDEN RE
    Proc Staff Meet Mayo Clin; 1949 Sep; 24(19):483-6. PubMed ID: 18138747
    [No Abstract]   [Full Text] [Related]  

  • 20. Reaction to diphenyl hydantoin sodium; report of a case simulating Rocky Mountain spotted fever and review of literature.
    STEINBERG SH
    Med Ann Dist Columbia; 1953 Nov; 22(11):600-3; passim. PubMed ID: 13098451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.